GlucoTrack Valuation
| GCTK Stock | USD 1.79 0.04 2.29% |
Based on Macroaxis valuation methodology, the firm appears to be overvalued. GlucoTrack retains a regular Real Value of $1.72 per share. The prevalent price of the firm is $1.79. Our model calculates the value of GlucoTrack from evaluating the firm fundamentals such as Shares Owned By Insiders of 6.46 %, return on equity of -14.91, and Return On Asset of -2.26 as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that GlucoTrack's price fluctuation is extremely dangerous at this time. Calculation of the real value of GlucoTrack is based on 3 months time horizon. Increasing GlucoTrack's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
GlucoTrack's intrinsic value may or may not be the same as its current market price of 1.79, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.79 | Real 1.72 | Hype 1.91 |
The intrinsic value of GlucoTrack's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence GlucoTrack's stock price.
Estimating the potential upside or downside of GlucoTrack helps investors to forecast how GlucoTrack stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of GlucoTrack more accurately as focusing exclusively on GlucoTrack's fundamentals will not take into account other important factors: GlucoTrack Cash |
|
About GlucoTrack Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of GlucoTrack. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of GlucoTrack based exclusively on its fundamental and basic technical indicators. By analyzing GlucoTrack's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of GlucoTrack's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of GlucoTrack. We calculate exposure to GlucoTrack's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of GlucoTrack's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -32.4 K | -30.8 K | |
| Pretax Profit Margin | (19.44) | (20.41) | |
| Operating Profit Margin | 15.17 | 14.41 | |
| Net Loss | (19.44) | (20.41) | |
| Gross Profit Margin | (1.38) | (1.31) |
GlucoTrack Current Valuation Indicators
GlucoTrack's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final GlucoTrack's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as GlucoTrack, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use GlucoTrack's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes GlucoTrack's worth.When determining whether GlucoTrack is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if GlucoTrack Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Glucotrack Stock. Highlighted below are key reports to facilitate an investment decision about Glucotrack Stock: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GlucoTrack. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more information on how to buy GlucoTrack Stock please use our How to buy in GlucoTrack Stock guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GlucoTrack. Market participants price GlucoTrack higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive GlucoTrack assessment requires weighing all these inputs, though not all factors influence outcomes equally.
The market value of GlucoTrack is measured differently than its book value, which is the value of GlucoTrack that is recorded on the company's balance sheet. Investors also form their own opinion of GlucoTrack's value that differs from its market value or its book value, called intrinsic value, which is GlucoTrack's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GlucoTrack's market value can be influenced by many factors that don't directly affect GlucoTrack's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GlucoTrack's value and its price as these two are different measures arrived at by different means. Investors typically determine if GlucoTrack is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, GlucoTrack's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.